Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019
Sylvia Ranjeva, Riccardo Pinciroli, Evan Hodell, et al.
EClinicalMedicine (2021) Vol. 34, pp. 100829-100829
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
Giacomo Grasselli, Carolyn S. Calfee, Luigi Camporota, et al.
Intensive Care Medicine (2023) Vol. 49, Iss. 7, pp. 727-759
Open Access | Times Cited: 395
Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts
Lieuwe D. J. Bos, Michael W. Sjoding, Pratik Sinha, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 12, pp. 1377-1386
Open Access | Times Cited: 65
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update
Paolo Pelosi, Roberto Tonelli, Chiara Torregiani, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1704-1704
Open Access | Times Cited: 59
Therapeutic Effects of Inhaled Nitric Oxide Therapy in COVID-19 Patients
N. O. Kamenshchikov, Lorenzo Berra, Ryan W. Carroll
Biomedicines (2022) Vol. 10, Iss. 2, pp. 369-369
Open Access | Times Cited: 32
Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
Gerard J. Criner, Frederick Lang, Robert Gottlieb, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 11, pp. 1290-1299
Open Access | Times Cited: 28
Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
Justin de Brabander, Erik Duijvelaar, Job R. Schippers, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2200780-2200780
Open Access | Times Cited: 28
Clinical Sepsis Phenotypes in Critically Ill Patients
Γεώργιος Παπαθανάκος, Ioannis Andrianopoulos, Menelaos Xenikakis, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2165-2165
Open Access | Times Cited: 18
Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies
Wen Ma, Songling Tang, Yao Peng, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Early alveolar epithelial cell necrosis is a potential driver of COVID-19-induced acute respiratory distress syndrome
Kentaro Tojo, Natsuhiro Yamamoto, Nao Tamada, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105748-105748
Open Access | Times Cited: 22
Transcriptomic clustering of critically ill COVID-19 patients
Cecilia López‐Martínez, Paula Martín-Vicente, Juan Gómez de Oña, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2200592-2200592
Open Access | Times Cited: 18
Hemorrhage, Disseminated Intravascular Coagulopathy, and Thrombosis Complications Among Critically Ill Patients with COVID-19: An International COVID-19 Critical Care Consortium Study*
Jonathon P. Fanning, Natasha Weaver, Robert B. Fanning, et al.
Critical Care Medicine (2023) Vol. 51, Iss. 5, pp. 619-631
Open Access | Times Cited: 10
Glucocorticoid Therapy in COVID-19
Francesco Amati, Antonio Tonutti, John C. Huston, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 100-117
Closed Access | Times Cited: 9
Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial
Narges Alipanah, James Hurst‐Hopf, Kevin Delucchi, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 2
Identification of Endotypes of Hospitalized COVID-19 Patients
Benjamin L. Ranard, Murad Megjhani, Kalijah Terilli, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 18
Multitask Learning With Recurrent Neural Networks for Acute Respiratory Distress Syndrome Prediction Using Only Electronic Health Record Data: Model Development and Validation Study
Carson Lam, Rahul Thapa, Jenish Maharjan, et al.
JMIR Medical Informatics (2022) Vol. 10, Iss. 6, pp. e36202-e36202
Open Access | Times Cited: 13
Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review
Seth Kwabena Amponsah, Benjamin Tagoe, Ismaila Adams, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Phenotyping COVID-19 respiratory failure in spontaneously breathing patients with AI on lung CT-scan
Emanuele Rezoagli, Yi Xin, Davide Signori, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 1
Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis
Satoshi Gando, Takeshi Wada
Shock (2021) Vol. 57, Iss. 1, pp. 1-6
Open Access | Times Cited: 11
Protective ventilation in patients with acute respiratory distress syndrome related to COVID-19: always, sometimes or never?
Chiara Mega, Irene Cavalli, V. Marco Ranieri, et al.
Current Opinion in Critical Care (2021) Vol. 28, Iss. 1, pp. 51-56
Open Access | Times Cited: 10
What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders
Enrico Maggi, Bruno Azzarone, Giorgio Walter Canonica, et al.
Allergy (2021) Vol. 77, Iss. 4, pp. 1114-1128
Open Access | Times Cited: 7
Latent class analysis: an innovative approach for identification of clinical and laboratory markers of disease severity among COVID-19 patients admitted to the intensive care unit
Lovemore N. Sigwadhi, Jacques L. Tamuzi, Annalise E. Zemlin, et al.
IJID Regions (2022) Vol. 5, pp. 154-162
Open Access | Times Cited: 5
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19
John Cafardi, Carole B. Miller, Howard R. Terebelo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2242918-e2242918
Open Access | Times Cited: 5
Machine learning-based COVID-19 acute respiratory distress syndrome phenotyping and clinical outcomes: A systematic review
Eric Daniel Tenda, Joshua Henrina, Jistrani Samosir, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17276-e17276
Open Access | Times Cited: 2
HYDROCORTISONE, ASCORBIC ACID, AND THIAMINE THERAPY DECREASE RENAL OXIDATIVE STRESS AND ACUTE KIDNEY INJURY IN MURINE SEPSIS
John Kim, Allan E. Stolarski, Qiuyang Zhang, et al.
Shock (2022) Vol. 58, Iss. 5, pp. 426-433
Open Access | Times Cited: 4
Endotyping in ARDS: one step forward in precision medicine
Andréanne Côté, Chel Hee Lee, Sayed Metwaly, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top